GLOW is Wolverine plus one (repair plus skin/collagen)
The Federal Trade Commission (FTC) investigated Noom's weight-loss claims in 2021, settling allegations of unsubstantiated advertising
Kent Heberer, New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans with Type 2 Diabetes February 10, 2026- Novo Nordisk sues Hims and Hers for compounded Ozempic knockoff Novo Nordisk declared that it is pursuing an Ozempic lawsuit against telemedicine platform Hims & Hers for purportedly deceiving patients and putting their health at risk by marketing and distributing compounded knockoff versions of Ozempic and Wegovy drugs
These updated warnings include further advice for patients using oral contraceptives: Patients taking tirzepatide are advised to switch to a non-oral contraceptive or add a barrier method of contraception for 4 weeks after first taking the medicine and for 4 weeks after each increase in the dose
In most cases, insurance does not cover compounded peptide therapies as they are not FDA-approved drugs
This approval came after Novo Nordisk's Saxenda formulation demonstrated efficacy in reducing body weight by an average of 1015% in clinical trials
